Cited by 2,614Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionCutaneous Melanoma Detection and Management

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Open access
Allemani, Claudia, Weir, Hannah K, Carreira, Helena, Harewood, Rhea, Spika, Devon, Wang, Xiao-Si, Bannon, Finian, Ahn, Jane V +15 more·2015·The Lancet

Abstract

Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control.Methods Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights.Findings 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease.Interpretation International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems.Funding Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)62038-9

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [41]Elandt-Johnson RC Johnson NL Survival models and data analysis (Wiley series in probability and mathematical statistics) 1980 John Wiley & Sons Indianapolis
  2. [64]Sankaranarayanan R Black RJ Parkin DM Cancer survival in developing countries (IARC scientific publications no 145) 1998 International Agency for Research on Cancer Lyon 10194635
  3. [108]Bray F Znaor A Cueva P Planning and developing population-based cancer registration in low- and middle-income settings (IARC technical publication no 43) 2014 International Agency for Research on Cancer Lyon 33502836

Cited by

Sorted by citations

Authors
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., Marcos-Gragera, R., Stiller, C., Azevedo e Silva, G., Chen, W.-Q., Ogunbiyi, O. J., Rachet, B., Soeberg, M. J., You, H., Matsuda, T., Bielska-Lasota, M., Storm, H., Tucker, T. C., & Coleman, M. P.
Affiliations
  • Cancer Research UK (GB)
  • Centers for Disease Control and Prevention (US)
  • Queen's University Belfast (GB)
  • Public Health England (GB)
  • University College Hospital, Ibadan (NG)
  • Cancer Institute of New South Wales (AU)
  • National Cancer Centre Japan (JP)
  • Danish Cancer Society (DK)
  • University of Kentucky (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-03
Volume
385
Issue
9972
Pages
977-1010
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2112657305
Cited by
2,614
References
113
Citations by year
2026: 58 · 2025: 116 · 2024: 141 · 2023: 171 · 2022: 212 · 2021: 270 · 2020: 245 · 2019: 218 · 2018: 282 · 2017: 415 · 2016: 283 · 2015: 194 · 2014: 3 · 2013: 1
FWCI
144.12
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Tampere University Institutional Repository (Tampere University) (publishedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Universitat de Girona Digital Repository (Universitat de Girona) (acceptedVersion, cc-by)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • Unicam Scientific Publications (University of Camerino) (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • IRIS (submittedVersion)
  • IRIS UniPA (University of Palermo) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion, cc-by)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, other-oa)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
  • Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders
  • U.S. Department of Health and Human Services
  • World Bank Group
  • New York City Department of Health and Mental Hygiene
  • Pennsylvania Department of Health
  • University of Kentucky (3049024672-12-568)
  • Cancer Care Ontario
  • London School of Hygiene and Tropical Medicine
  • Ohio Department of Health
  • ACT Government
  • Cancer Research UK (C1336/ A16148, 16148, A16148, C1336, 18525)
  • National Institute for Health and Care Research
  • Cancer Institute NSW
  • Universitat de València
  • International Atomic Energy Agency
  • Institut National Du Cancer
  • Swiss Re
  • Regione Toscana
  • Swiss Cancer Research Foundation
  • Partenariat Canadien Contre Le Cancer
  • National Institutes of Health (CC999999)
  • Centers for Disease Control and Prevention (12FED03123, ACO12036)
  • BC Cancer Agency
  • National Cancer Institute (P30CA177558)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
Keywords
cancer survival, net survival, population-based cancer registry, colon cancer, rectal cancer, breast cancer, prostate cancer, lung cancer, liver cancer, cervical cancer, ovarian cancer, pediatric leukemia, childhood cancer, survival trends, health system effectiveness, cancer control policy, cross-national comparison, registry data quality
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Neoplasms, Registries, Global Health, Survival Analysis, Age Distribution, Sex Distribution, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review